NCT02979756

Brief Summary

A situational analysis on gestational diabetes conducted in 2015 in two districts in Morocco revealed difficulties in accessing screening for gestational diabetes (GDM) and delays in receiving appropriate care. Based on the results of the situational analysis, the investigators developed this proposal in close collaboration with the Moroccan research group on gestational diabetes composed of representatives of the Ministry of Health, researchers, members of professional organizations and specialists in the domains of endocrinology, gynecology, neonatal health and nutrition. The investigators opted for an hybrid implementation effectiveness trial to evaluate both clinical effectiveness of the proposed screening and initial management strategy and its implementation at the first level of care. The objectives of this study are thus to evaluate the feasibility of a decentralized strategy of screening for GDM and the initialization of GDM treatment already through the primary level of care and to assess its potential for scaling-up. Specific objectives of this study are to augment universal access to screening and management of gestational diabetes and to increase the competencies of health care providers at first level health care facilities to detect, start initial treatment and to improve follow-up of affected women. By comparing active screening and treatment initiation through first line health facilities with the existing practices, the investigators would like to explore the effect of the new model on maternal and newborn outcomes such as weight gain in pregnancy, occurrence of delivery complications and birth weight. The investigators will further assess the acceptability of screening and initial management of GDM through first line health services by health care providers and by pregnant women diagnosed with GDM and the impact of two different screening approaches on the lifestyle of affected mothers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
215

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 14, 2016

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

November 22, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 2, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2018

Completed
Last Updated

March 1, 2018

Status Verified

February 1, 2018

Enrollment Period

1.1 years

First QC Date

November 22, 2016

Last Update Submit

February 28, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Macrosomia

    Difference in birth weight of babies of mothers detected with GDM in the different arms

    within 6 months after being diagnosed with GDM

Secondary Outcomes (2)

  • Acceptance of GDM screening

    within 6 months after being diagnosed with GDM

  • Lifestyle impact of GDM

    within 6 months after being diagnosed with GDM

Study Arms (2)

Decentralized GDM screening and initial management

EXPERIMENTAL

In this arm, the intervention consists of screening all pregnant women for GDM using the nationally recommended oral glucose tolerance test that will take place during antenatal care consultations in 10 randomly selected primary health care facilities. Overall, 80 women who are diagnosed with GDM and who consent to participate will receive initial nutritional counseling and will be closely followed up.

Procedure: Decentralized GDM screening and initial management

Standard GDM screening and management practice

NO INTERVENTION

In this arm, screening for GDM will follow standard practice. 80 women diagnosed with GDM in 10 randomly selected primary health care facilities and who consent to participate will be followed up.

Interventions

Screening for GDM and initialization of nutritional therapy at the first level of care

Decentralized GDM screening and initial management

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women attending ANC (screening)
  • Women diagnosed with GDM (follow-up)
  • Informed consent

You may not qualify if:

  • Pregnant women with pre-existing diabetes type 1 or 2
  • No informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

20 facilities in Marrakech and Al Haouz - Region Marrakech-Safi

Marrakesh, 40000, Morocco

Location

Related Publications (3)

  • Utz B, Assarag B, Lekhal T, Van Damme W, De Brouwere V. Implementation of a new program of gestational diabetes screening and management in Morocco: a qualitative exploration of health workers' perceptions. BMC Pregnancy Childbirth. 2020 May 24;20(1):315. doi: 10.1186/s12884-020-02979-9.

  • Utz B, Assarag B, Smekens T, Ennassiri H, Lekhal T, El Ansari N, Fakhir B, Barkat A, Essolbi A, De Brouwere V. Detection and initial management of gestational diabetes through primary health care services in Morocco: An effectiveness-implementation trial. PLoS One. 2018 Dec 28;13(12):e0209322. doi: 10.1371/journal.pone.0209322. eCollection 2018.

  • Utz B, Assarag B, Essolbi A, Barkat A, El Ansari N, Fakhir B, Delamou A, De Brouwere V. Improving detection and initial management of gestational diabetes through the primary level of care in Morocco: protocol for a cluster randomized controlled trial. Reprod Health. 2017 Jun 19;14(1):75. doi: 10.1186/s12978-017-0336-z.

Study Officials

  • Bouchra Assarag, MD

    Ecole Nationale de Santé Publique, Rabat, Morocco

    PRINCIPAL INVESTIGATOR
  • Bettina Utz, MD

    Institute of Tropical Medicine, Antwerp, Belgium

    PRINCIPAL INVESTIGATOR
  • Vincent De Brouwere, MD

    Institute of Tropical Medicine, Antwerp, Belgium

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2016

First Posted

December 2, 2016

Study Start

November 14, 2016

Primary Completion

December 15, 2017

Study Completion

February 12, 2018

Last Updated

March 1, 2018

Record last verified: 2018-02

Locations